Date published: 2026-4-25

1-800-457-3801

SCBT Portrait Logo
Seach Input

CECR2 Activators

The chemical class known as CECR2 activators encompasses a group of compounds that modulate the activity of the calcium-binding protein CECR2, standing for Cat Eye Syndrome Chromosome Region, Candidate 2. CECR2 is associated with chromatin remodeling, and its activation or modulation plays a pivotal role in the regulation of various cellular processes. Structurally, CECR2 activators often interact with specific binding sites on the protein, inducing conformational changes that subsequently impact its functional properties. These activators can act as allosteric modulators, influencing the protein's ability to bind to chromatin and participate in epigenetic regulation.

The precise mechanisms through which CECR2 activators exert their effects remain an active area of research. Some compounds may enhance the affinity of CECR2 for its binding partners, while others may alter its intracellular localization. Understanding the structural and biochemical details of CECR2 activation is crucial for unraveling the intricate web of cellular events regulated by this protein. As researchers delve deeper into the molecular intricacies of CECR2 activation, the potential implications for cellular physiology and function become increasingly apparent. The exploration of CECR2 activators sheds light on the dynamic interplay between chromatin remodeling proteins and cellular processes, contributing to the broader understanding of molecular mechanisms governing gene expression and cellular homeostasis.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Trichostatin A

58880-19-6sc-3511
sc-3511A
sc-3511B
sc-3511C
sc-3511D
1 mg
5 mg
10 mg
25 mg
50 mg
$152.00
$479.00
$632.00
$1223.00
$2132.00
33
(3)

HDAC Inhibitor; Enhances histone acetylation, potentially indirectly activating CECR2 by modulating the acetylation status of histones.

Suberoylanilide Hydroxamic Acid

149647-78-9sc-220139
sc-220139A
100 mg
500 mg
$133.00
$275.00
37
(2)

HDAC Inhibitor; Induces histone hyperacetylation, potentially indirectly activating CECR2 by altering the acetylation state of histones.

Valproic Acid

99-66-1sc-213144
10 g
$87.00
9
(1)

HDAC Inhibitor; Alters histone acetylation levels, potentially activating CECR2 by modulating the acetylation status of histones.

Curcumin

458-37-7sc-200509
sc-200509A
sc-200509B
sc-200509C
sc-200509D
sc-200509F
sc-200509E
1 g
5 g
25 g
100 g
250 g
1 kg
2.5 kg
$37.00
$69.00
$109.00
$218.00
$239.00
$879.00
$1968.00
47
(1)

HAT Activator; Enhances histone acetylation, potentially indirectly activating CECR2 through promotion of histone acetylation.

Anacardic Acid

16611-84-0sc-202463
sc-202463A
5 mg
25 mg
$102.00
$204.00
13
(1)

HAT Activator; Modulates histone acetylation, potentially activating CECR2 by influencing the acetylation state of histones.

(±)-JQ1

1268524-69-1sc-472932
sc-472932A
5 mg
25 mg
$231.00
$863.00
1
(0)

BRD4 Inhibitor; Targets bromodomain-containing proteins, possibly indirectly activating CECR2 through modulation of the bromodomain-dependent chromatin interactions.

C646

328968-36-1sc-364452
sc-364452A
10 mg
50 mg
$265.00
$944.00
5
(1)

p300/CBP Inhibitor; Blocks histone acetylation, potentially indirectly activating CECR2 by disrupting the histone acetylation machinery.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

PI3K Inhibitor; Modulates PI3K/Akt signaling, potentially indirectly activating CECR2 by influencing the PI3K/Akt pathway, which may intersect with CECR2-related processes.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$63.00
$158.00
$326.00
233
(4)

mTOR Inhibitor; Inhibits mTOR signaling pathway, potentially indirectly activating CECR2 through modulation of the mTOR pathway, which could be connected to CECR2-related functions.

XAV939

284028-89-3sc-296704
sc-296704A
sc-296704B
1 mg
5 mg
50 mg
$36.00
$117.00
$525.00
26
(1)

Tankyrase Inhibitor; Modulates Wnt/β-Catenin pathway, potentially indirectly activating CECR2 by influencing the Wnt/β-Catenin pathway, which may intersect with CECR2-related processes.